98 related articles for article (PubMed ID: 27168139)
1. Detrimental effects of a bout of physical exercise on circulating endogenous inhibitors of endothelial function in patients with coronary artery disease.
Ilic MD; Pavlovic R; Lazarevic G; Zivanovic S; Cvetkovic T; Kocic G; Ilic S; Ambrosio G
J Cardiovasc Med (Hagerstown); 2017 Aug; 18(8):610-616. PubMed ID: 27168139
[TBL] [Abstract][Full Text] [Related]
2. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
Lu TM; Ding YA; Charng MJ; Lin SJ
Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
[TBL] [Abstract][Full Text] [Related]
3. Association of asymmetric dimethylarginine levels with treadmill-stress-test-derived prognosticators.
Deftereos S; Bouras G; Tsounis D; Papadimitriou C; Hatzis G; Raisakis K; Panagopoulou V; Kaoukis A; Ioannidis A; Deftereos G; Kossyvakis C; Manolis AS; Alexopoulos D; Stefanadis C; Cleman MW; Giannopoulos G
Clin Biochem; 2014 May; 47(7-8):593-8. PubMed ID: 24525256
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients.
Turiel M; Atzeni F; Tomasoni L; de Portu S; Delfino L; Bodini BD; Longhi M; Sitia S; Bianchi M; Ferrario P; Doria A; De Gennaro Colonna V; Sarzi-Puttini P
Rheumatology (Oxford); 2009 Jul; 48(7):834-9. PubMed ID: 19465588
[TBL] [Abstract][Full Text] [Related]
5. Physical exercise reduces synthesis of ADMA, SDMA, and L-Arg.
Riccioni G; Scotti L; Guagnano MT; Bosco G; Bucciarelli V; Di Ilio E; Speranza L; Martini F; Bucciarelli T
Front Biosci (Elite Ed); 2015 Jun; 7(3):417-22. PubMed ID: 25961421
[TBL] [Abstract][Full Text] [Related]
6. Parental history of premature coronary artery disease does not affect plasma levels of asymmetric dimethylarginine in young healthy adults.
Surdacki A; Zawiślak B; Rakowski T; Wieczorek-Surdacka E; Fedak D; Dubiel JS
Pol Arch Med Wewn; 2012; 122(10):487-93. PubMed ID: 23022711
[TBL] [Abstract][Full Text] [Related]
7. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
Thum T; Tsikas D; Stein S; Schultheiss M; Eigenthaler M; Anker SD; Poole-Wilson PA; Ertl G; Bauersachs J
J Am Coll Cardiol; 2005 Nov; 46(9):1693-701. PubMed ID: 16256870
[TBL] [Abstract][Full Text] [Related]
8. Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: A meta-analysis based on 4713 participants.
Xuan C; Tian QW; Li H; Zhang BB; He GW; Lun LM
Eur J Prev Cardiol; 2016 Mar; 23(5):502-10. PubMed ID: 25956428
[TBL] [Abstract][Full Text] [Related]
9. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
Wang J; Sim AS; Wang XL; Salonikas C; Naidoo D; Wilcken DE
Atherosclerosis; 2006 Feb; 184(2):383-8. PubMed ID: 15939423
[TBL] [Abstract][Full Text] [Related]
10. Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions.
Erdélyi-Bótor S; Komáromy H; Kamson DO; Kovács N; Perlaki G; Orsi G; Molnár T; Illes Z; Nagy L; Kéki S; Deli G; Bosnyák E; Trauninger A; Pfund Z
Cephalalgia; 2017 May; 37(6):571-580. PubMed ID: 27206959
[TBL] [Abstract][Full Text] [Related]
11. Increased symmetric dimethylarginine, but not asymmetric dimethylarginine, concentrations are associated with transient myocardial ischemia and predict outcome.
Szabo Z; Bartha E; Nagy L; Molnar T
J Int Med Res; 2020 Jun; 48(6):300060520920439. PubMed ID: 32529878
[TBL] [Abstract][Full Text] [Related]
12. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease.
Bode-Böger SM; Scalera F; Kielstein JT; Martens-Lobenhoffer J; Breithardt G; Fobker M; Reinecke H
J Am Soc Nephrol; 2006 Apr; 17(4):1128-34. PubMed ID: 16481412
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
[TBL] [Abstract][Full Text] [Related]
14. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma.
Javadiyan S; Burdon KP; Whiting MJ; Abhary S; Straga T; Hewitt AW; Mills RA; Craig JE
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1923-7. PubMed ID: 22395885
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric and symmetric dimethylarginine are associated with coronary artery lesions in Kawasaki disease.
Huang YH; Tain YL; Lee CP; Kuo HC
J Pediatr; 2014 Aug; 165(2):295-9. PubMed ID: 24874168
[TBL] [Abstract][Full Text] [Related]
16. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
Antoniades C; Shirodaria C; Leeson P; Antonopoulos A; Warrick N; Van-Assche T; Cunnington C; Tousoulis D; Pillai R; Ratnatunga C; Stefanadis C; Channon KM
Eur Heart J; 2009 May; 30(9):1142-50. PubMed ID: 19297385
[TBL] [Abstract][Full Text] [Related]
17. Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization.
Frøbert O; Hjortshøj SP; Simonsen U; Ravkilde J
Int J Cardiol; 2008 Sep; 129(2):288-91. PubMed ID: 17689741
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis.
Weis M; Kledal TN; Lin KY; Panchal SN; Gao SZ; Valantine HA; Mocarski ES; Cooke JP
Circulation; 2004 Feb; 109(4):500-5. PubMed ID: 14732750
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric dimethylarginine levels in thyroid diseases.
Arikan E; Karadag CH; Guldiken S
J Endocrinol Invest; 2007 Mar; 30(3):186-91. PubMed ID: 17505150
[TBL] [Abstract][Full Text] [Related]
20. Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease.
Wolf C; Lorenzen JM; Stein S; Tsikas D; Störk S; Weidemann F; Ertl G; Anker SD; Bauersachs J; Thum T
Int J Cardiol; 2012 May; 156(3):289-94. PubMed ID: 21159392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
